Reuters: Mergers News: CORRECTED-BRIEF-Human Genome Sciences rejects GSK's $13 per share offer

Reuters: Mergers News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

CORRECTED-BRIEF-Human Genome Sciences rejects GSK's $13 per share offer Jun 1st 2012, 18:09 Fri Jun 1, 2012 2:09pm EDT * Says HGS board of directors has rejected GSK's unsolicited $13.00 per share offer * Says HGS board of directors recommends that HGS stockholders reject GSK's tender offer * Says "concluding unanimously that the GSK offer is inadequate, does not reflect the value inherent in HGS" * Exploration of strategic alternatives continues to be active and fully underway"

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions